UPDATED Jul 23, 2022
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
A038290Macrogen | â‚©26,100.00 | 0.6% | -29.8% | â‚©263.8b | â‚©40,000.00 | PE62.6x | E41.1% | 1.1% | ||
A001060JW Pharmaceutical | â‚©24,550.00 | -0.6% | -13.4% | â‚©544.0b | â‚©35,500.00 | PE120.1x | E43.6% | 1.3% | ||
A243070Huons | â‚©37,000.00 | 0.8% | -35.7% | â‚©437.7b | â‚©56,000.00 | PE14.3x | E21.3% | 1.5% | ||
A214450PharmaResearch | â‚©65,100.00 | 1.1% | -26.4% | â‚©649.4b | â‚©105,000.00 | PE14.8x | E17.5% | 0.9% | ||
A053030BINEX | â‚©14,750.00 | -2.6% | -24.9% | â‚©456.1b | â‚©21,500.00 | PE36.3x | E24.1% | n/a | ||
A016580Whan In PharmLtd | â‚©17,000.00 | 0.9% | -21.7% | â‚©259.5b | â‚©24,000.00 | PE10.4x | E6.9% | 1.8% | ||
A000640Dong-A Socio Holdings | â‚©103,500.00 | -2.8% | -17.9% | â‚©646.9b | â‚©150,000.00 | PE11.6x | E15.1% | 1.0% | ||
A003220Daewon Pharmaceutical | â‚©18,200.00 | -4.2% | 15.7% | â‚©386.0b | â‚©22,526.21 | PE15.1x | E9.0% | 1.1% |